Cargando…
Diffuse goitre enlargement after immunotherapy for non‐small cell lung cancer
It is well known that a phenomenon called hyperprogressive disease (HPD) often occurs during immunotherapy with immune checkpoint inhibitors. In the present case, we experienced a case of HPD in a potential metastatic thyroid tumour during immunotherapy. HPD can be life‐threatening depending on wher...
Autores principales: | Fujita, Kohei, Araki, Norio, Mio, Tadashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8506638/ https://www.ncbi.nlm.nih.gov/pubmed/34667615 http://dx.doi.org/10.1002/rcr2.866 |
Ejemplares similares
-
Small cell lung cancer transformation during immunotherapy with nivolumab: A case report
por: Imakita, Takuma, et al.
Publicado: (2017) -
Small cell transformation of non‐small cell lung cancer under immunotherapy: Case series and literature review
por: Imakita, Takuma, et al.
Publicado: (2021) -
Effect of cyclooxygenase inhibitor use on immunotherapy efficacy in non‐small cell lung cancer
por: Kanai, Osamu, et al.
Publicado: (2021) -
Goitre géant dyspnéisant
por: Ridal, Mohammed, et al.
Publicado: (2013) -
Acute onset of ulcerative colitis during chemoradiotherapy for anaplastic lymphoma kinase‐positive lung adenocarcinoma
por: Fujita, Kohei, et al.
Publicado: (2017)